Dirty and Dying, but US-Approved?
Problems with contamination and genetic abnormalities may not stop work on embryonic stem cell therapies
Problems with contamination and genetic abnormalities may not stop work on embryonic stem cell therapies
Adult stem cells may escape the ethical controversies of their embryonic counterparts, but as Christine Soares notes, their practical clinical value is far more murky
Buying time to arm for a pandemic is possible--maybe
Politics slow polio's eradication--and cause it to spread
Not much at the moment, thinks biologist Kevin de Queiroz, but names could be made to reflect our modern understanding of life's origins and complexity
Pathogens take windows of opportunity, and so must humans, says David L. Heymann, who helped to create a global early-warning and response network
Prescription privileges make some psychologists anxious
You have free articles left.
Support our award-winning coverage of advances in science & technology.
Already a subscriber? Sign in.